Baxter International Inc. (BAX) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Third Point LLC 23,008,125 株保有. その他の主要保有者には Hider Andrew P. および Grade Joel T..
過去12ヶ月間にインサイダーは 40 件の取引を実施 BAX 株式 — 18 件の買い (評価額 $14.55M) および 0 件の売り (評価額 RSU アワード). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.
BAX インサイダー保有状況
最大保有者
Third Point LLC
23,008,125 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Third Point Llc |
Director |
23,008,125 |
2019-05-17 |
|
| 2 |
Hider Andrew P. |
President and CEO |
488,506 |
2026-03-03 |
|
| 3 |
Grade Joel T. |
EVP and CFO |
271,674 |
2026-03-10 |
|
| 4 |
Almeida Jose E |
Chairman, CEO, President |
243,589 |
2024-12-17 |
|
| 5 |
Mason Jeanne K |
EVP, Chief HR Officer |
199,853 |
2025-12-16 |
|
| 6 |
Saccaro James |
EVP, Chief Financial Officer |
177,899 |
2023-03-06 |
|
| 7 |
Rosenbloom David S. |
EVP and General Counsel |
138,216 |
2026-03-10 |
|
| 8 |
Sonig Alok |
EVP,group President,pharma |
128,219 |
2025-09-04 |
|
| 9 |
Rasul Reazur |
EVP,group Pres,healthcare |
125,557 |
2026-03-10 |
|
| 10 |
Knight Heather |
EVP, Chief Operating Officer |
118,934 |
2025-03-10 |
|
| 11 |
Scharf David P. |
CVP and General Counsel |
109,789 |
2017-02-23 |
|
| 12 |
Toth Christopher A. |
EVP, Group Pres, Kidney Care |
105,186 |
2025-02-04 |
|
| 13 |
Franzi Cristiano |
SVP, President, Emea |
102,145 |
2023-03-06 |
|
| 14 |
Soriano Maria Cecilia |
Group Pres., Itt & Pharma. |
75,045 |
2026-03-10 |
|
| 15 |
Borzi James W |
EVP,chief Supply Chain Officer |
71,948 |
2025-09-04 |
|
| 16 |
Eyre Brik V |
SVP, President, Americas |
68,587 |
2019-03-04 |
|
| 17 |
Stevens Brian |
SVP, CAO & Controller |
67,538 |
2024-03-08 |
|
| 18 |
Shafer David Brent |
Other: Chair of the Board |
59,446 |
2025-08-21 |
|
| 19 |
Accogli Giuseppe |
EVP, Chief Operating Officer |
55,126 |
2022-03-04 |
|
| 20 |
Martin Sean |
SVP and General Counsel |
52,632 |
2022-03-04 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-03-06 |
Soriano Maria Cecilia |
Group Pres., Itt & Pharma. |
RSU 源泉徴収 |
2,848 |
$17.69 |
$50.38K |
| 2026-03-06 |
Rasul Reazur |
EVP,group Pres,healthcare |
RSU 源泉徴収 |
12,674 |
$17.69 |
$224.2K |
| 2026-03-06 |
Rosenbloom David S. |
EVP and General Counsel |
RSU 源泉徴収 |
6,620 |
$17.69 |
$117.11K |
| 2026-03-06 |
Zielinski Anita A |
SVP, CAO and Controller |
RSU 源泉徴収 |
1,932 |
$17.69 |
$34.18K |
| 2026-03-06 |
Grade Joel T. |
EVP and CFO |
RSU 源泉徴収 |
8,153 |
$17.69 |
$144.23K |
| 2026-03-02 |
Soriano Maria Cecilia |
Group Pres., Itt & Pharma. |
RSU 源泉徴収 |
1,852 |
$19.69 |
$36.47K |
| 2026-02-27 |
Soriano Maria Cecilia |
Group Pres., Itt & Pharma. |
RSU 付与(制限付株式) |
57,471 |
$20.37 |
$1.17M |
| 2026-02-27 |
Carlisle Cynthia |
Executive Vice President, Chro |
RSU 付与(制限付株式) |
17,806 |
- |
- |
| 2026-02-23 |
Carlisle Cynthia |
Executive Vice President, Chro |
不明 |
- |
- |
- |
| 2026-03-02 |
Rasul Reazur |
EVP,group Pres,healthcare |
RSU 源泉徴収 |
1,614 |
$19.69 |
$31.78K |
| 2026-02-27 |
Hider Andrew P. |
President and CEO |
RSU 付与(制限付株式) |
488,506 |
$20.37 |
$9.95M |
| 2026-03-02 |
Rosenbloom David S. |
EVP and General Counsel |
RSU 源泉徴収 |
1,336 |
$19.69 |
$26.31K |
| 2026-02-27 |
Rosenbloom David S. |
EVP and General Counsel |
RSU 付与(制限付株式) |
64,655 |
$20.37 |
$1.32M |
| 2026-02-27 |
Zielinski Anita A |
SVP, CAO and Controller |
RSU 付与(制限付株式) |
30,864 |
- |
- |
| 2026-02-27 |
Grade Joel T. |
EVP and CFO |
RSU 付与(制限付株式) |
103,448 |
$20.37 |
$2.11M |
| 2026-02-13 |
Mcdonnell Michael R. |
Director |
RSU 付与(制限付株式) |
1,811 |
- |
- |
| 2026-02-13 |
Mcdonnell Michael R. |
Director |
不明 |
- |
- |
- |
| 2026-02-09 |
Soriano Maria Cecilia |
Group Pres., Itt & Pharma. |
RSU 源泉徴収 |
918 |
$21.73 |
$19.95K |
| 2026-02-09 |
Rasul Reazur |
EVP,group Pres,healthcare |
RSU 源泉徴収 |
5,770 |
$21.73 |
$125.38K |
| 2026-02-09 |
Rosenbloom David S. |
EVP and General Counsel |
RSU 源泉徴収 |
5,225 |
$21.73 |
$113.54K |
| 2026-02-09 |
Grade Joel T. |
EVP and CFO |
RSU 源泉徴収 |
9,144 |
$21.73 |
$198.7K |
| 2025-12-12 |
Mason Jeanne K |
EVP, Chief HR Officer |
RSU 源泉徴収 |
650 |
$19.15 |
$12.45K |
| 2025-12-01 |
Soriano Maria Cecilia |
Group Pres., Itt & Pharma. |
不明 |
23,787 |
$35.44 |
$843.01K |
| 2025-12-01 |
Grade Joel T. |
EVP and CFO |
RSU 源泉徴収 |
8,288 |
$19.08 |
$158.14K |
| 2025-09-02 |
Sonig Alok |
EVP,group President,pharma |
RSU 源泉徴収 |
3,191 |
$24.17 |
$77.13K |